ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. It operates through two segments, Clinical Research and Central Laboratory. The Clinical Research segment specializes in strategic development, management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies. Its clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. This segment's clinical research services also comprise marker access and commercialization services, strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, pricing and market access consulting, medical imaging, contract staffing, and electronic endpoint adjudication. The Central Laboratory segment offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.